Llwytho...
Neuropharmacological Actions of Metformin in Stroke
Increasing epidemiologic evidence suggests that metformin, a well-established AMPK activator and the most favorable first-line anti-diabetic drug, reduces stroke incidence and severity. However, the mechanism for this remains unclear. Moreover, previous experimental studies have reported controversi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Neuropharmacol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Bentham Science Publishers
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4812800/ https://ncbi.nlm.nih.gov/pubmed/26411966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150205143555 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|